Clareon® Vivity® Extended Depth of Focus (EDOF) IOL | Alcon AU & NZ
MyAlcon Professional Logo
Online Store
MyAlcon for Consumers

MyAlcon | Australia and New Zealand

This page is available in English. Select below for other locations.

Select another location

Clareon® Vivity® IOL

Simplifying Presbyopia Correction1-8

 

A presbyopia-correcting IOL with wavefront-shaping technology, excellent clarity, and a visual disturbance profile comparable to a monofocal IOL1-4,9

Clareon® Vivity® IOL

Simplifying Presbyopia Correction1-8

 

A presbyopia-correcting IOL with wavefront-shaping technology, excellent clarity, and a visual disturbance profile comparable to a monofocal IOL1-4,9

 

Clareon® Vivity® Simplifies Presbyopia Correction1-8

 

Clareon® Vivity® provides the same excellent performance you expect with AcrySof IQ Vivity®, available on Alcon’s most advanced lens platform.

 

  • A visual disturbance profile comparable to a monofocal IOL1,3,4

 

  • Excellent distance, intermediate and functional near vision3,4*

 

  • Presbyopia-correcting performance in an easy-to-use wavefront-shaping IOL1-8

 

  • Excellent clarity† and stability on Alcon’s most advanced IOL platform to date9

 

*Results from a prospective, randomized, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof IQ Vivity® Extended Vision IOL and 113 with the AcrySof® IQ IOL with 6 months’ follow-up.

†Among the lowest levels of surface haze, SSNGs, and glistenings of competitive IOLs.

An image of a Clareon Vivity and Clareon Vivity Toric IOL overlapping each other.

Clareon® Vivity® is Designed to Deliver Excellent Distance, Intermediate and Functional Near Vision3,4

Icon of a car with text reading 'Monofocal-quality distance vision 6/6
Icon of a car with text reading 'Monofocal-quality distance vision 6/6

High-quality distance vision comparable to a monofocal

Binocular Mean Uncorrected Distance Visual Acuity (4 m)3,4*†

Icon of a computer monitor with text 'Excellent intermediate vision greater than 6/7.5.’
Icon of a computer monitor with text 'Excellent intermediate vision greater than 6/7.5.’

Improved intermediate visual acuity compared to a monofocal

Binocular Mean Uncorrected Intermediate Visual Acuity (66 cm)3,4*†

Icon of a smartphone with text 'Functional near vision 6/9.5’
Icon of a smartphone with text 'Functional near vision 6/9.5’

Functional near vision for close-up daily activities

Binocular Mean Uncorrected Near Visual Acuity (40 cm)3,4*†

Results from a prospective, randomized, parallel-group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof IQ Vivity® Extended Vision IOL and 113 with the AcrySof® IQ IOL with 6 months’ follow-up.

†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.

The Flat Defocus Curve Delivers Confidence in Hitting a Refractive Target3

 

6-month binocular distance corrected defocus curve3*†

Defocus curve graph showing that the defocus range for Clareon Vivity is comparable to that of a monofocal. A number one in a circle draws a line across the distance section of the graph, indicating that the Clareon Vivity IOL is designed to be forgiving and flexible around distance. A number two in a circle draws a line from the distance section of the graph to the near section indicating that Clareon Vivity offers a continuous intermediate range of vision.

*Data obtained from a prospective, randomized controlled trial of 145 subjects bilaterally implanted with the AcrySof IQ Vivity® Extended Vision IOL and 106 with the AcrySof® IQ IOL with 6 months’ follow-up.

†AcrySof IQ Vivity® was tested. AcrySof IQ Vivity® and Clareon® Vivity® are optically equivalent.

‡Monofocal IOL = Model SN60WF

§Vivity® IOL = Model DFT015

Visual Disturbance Profile: Clareon® Vivity® Had an Optical Halo Compared to a Monofocal IOL18

Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Monofocal IOL.
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Monofocal IOL.

 

Clareon®
Monofocal IOL
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Vivity IOL.
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Vivity IOL.

 

Clareon® Vivity®
IOL
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for Clareon PanOptix IOL.
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for Clareon PanOptix IOL.

 

Clareon®
PanOptix® IOL
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for TECNIS Synergy IOL.
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for TECNIS Synergy IOL.

 

TECNIS Synergy*
IOL

These are representative images from a benchtop study.

*Trademarks are the property of their respective owners.

Optical bench halo measurements: 4.5 mm pupil size18

Visual Disturbance Profile: Clareon® Vivity® Had an Optical Halo Compared to a Monofocal IOL5,18

 

Optical bench halo measurements: 4.5 mm pupil size5,18

Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Monofocal IOL.
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Monofocal IOL.

 

Clareon®
Monofocal IOL
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Vivity IOL.
Black background with a bright light in the middle representing the optical bench halo measurement for Clareon Vivity IOL.

 

Clareon® Vivity®
IOL
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for TECNIS Symfony Diffractive IOL.
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for TECNIS Symfony Diffractive IOL.

 

TECNIS Symfony*
Diffractive EDoF
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for Zeiss AT LARA Diffractive IOL.
Black background with a bright light in the middle, with a halo around the light larger than the Clareon Monofocal and Clareon Vivity IOLs, representing the optical bench halo measurement for Zeiss AT LARA Diffractive IOL.

 

Zeiss AT LARA*
Diffractive EDoF

These are representative images from a benchtop study.

*Trademarks are the property of their respective owners.

Clareon® Vivity® IOL Visual Disturbance Profile is Comparable to a Monofocal1,3,4

 

The majority of Vivity® IOL patients were not bothered at all by visual disturbances.1,3,4

Bar chart comparing patient reports of starbursts, halos, and glare with Vivity® IOL vs monofocal IOL. Most patients in both groups were not bothered at all, with similar low rates of visual disturbances.

*Results from a prospective, randomized, parallel group, subject and assessor masked, multisite trial of 107 subjects bilaterally implanted with AcrySof IQ Vivity® Extended Vision IOL and 113 with AcrySof® IQ IOL with 6 months follow-up. Visual disturbances were evaluated subjectively through QUVID questionnaire. Patients were asked: “In the past 7 days, how much were you bothered with starbursts, halos, and glare?”

†Vivity® IOL = AcrySof IQ Vivity®, Model DFT015

‡Monofocal IOL = AcrySof® IQ IOL, Model SN60WF

    NIGHTTIME

    Clinically Proven Low Rate of Visual Disturbances1-4

    The picture on the left displays the night-driving vision of someone with a monofocal IOL, with near objects out of focus.
    The image on the right displays the night-driving vision of someone with a Clareon Vivity IOL, with near, intermediate and distance focal points in focus.
    Vision Simulation: Night-time Activity
    DAYTIME

    Clareon® Vivity® IOL Delivers Excellent Distance, Intermediate and Functional Near Vision3,4

    The picture on the left displays this point of view from someone with a monofocal IOL. There are three grey circles with text. Each circle highlights the vision of someone with a monofocal IOL at near, intermediate and far distance, with near and intermediate focal points out of focus, and distance focal points in clear focus.
    The image on the right displays this point of view from someone with a Clareon Vivity IOL. There are three blue circles with text. Each circle highlights the vision of someone with the Clareon Vivity IOL at near, intermediate and far distance, with all focal points in clear focus.
    Vision Simulation: Day-time Activity
    SMART Educator

    In All Light Conditions, Vivity® Patients Reported Monofocal-Quality Distance with Excellent Intermediate and Functional Near Vision4

     

    Percent of Patients Reporting Good or Very Good Vision Without Spectacles at 6 Months4*†

    Bar charts comparing Vivity® IOL and monofocal IOL under day (3.0 mm pupil) and night (4.5 mm pupil) conditions. Vivity shows higher visual performance in both bright and dim settings.

    *Data obtained from a validated IOLSAT questionnaire, patients were asked, "How well did you see without wearing eyeglasses in the past 7 days?”

    †Results from a prospective, randomized, parallel group, subject and assessor masked, multisite trial of 107 subjects bilaterally implanted with AcrySof IQ Vivity® Extended Vision IOL and 113 with AcrySof® IQ IOL with 6 months follow-up.

    ‡Vivity® IOL = AcrySof IQ Vivity®, Model DFT015

    §Monofocal IOL = AcrySof® IQ IOL, Model SN60WF

    Blue logo of a weight scale
    Blue logo of a weight scale

    Clareon® Vivity® and AcrySof IQ Vivity® are Optically and Mechanically Equivalent

    An icon of white crosshairs appearing over a blue background.
    An icon of white crosshairs appearing over a blue background.

     

    IOLs based on Clareon® and AcrySof® have the lowest axial displacement and simulated dioptric power shift ​versus competitor IOLs13​*

    An icon of a diamond appearing over a blue background.
    An icon of a diamond appearing over a blue background.

     

    IOLs based on Clareon® deliver among the lowest levels of haze and roughness, SSNGs and glistenings compared with other IOLs9-12**

    An icon of a Vivity IOL with degree measurements on either side to signify axial displacement appearing over a blue background.
    An icon of a Vivity IOL with degree measurements on either side to signify axial displacement appearing over a blue background.

     

    Along with minimal axial displacement, the Clareon® haptic design, shared with AcrySof® IQ IOLs, contributes to a high rotational stability14

    An icon of a clipboard with checkmarks appearing over a blue background.
    An icon of a clipboard with checkmarks appearing over a blue background.

     

    Additionally, Clareon® and AcrySof® demonstrate Nd:YAG rates that are similar15-17

    *Based on comparison of the mean axial displacement of Clareon®, AcrySof®, enVista† MX60, TECNIS† ZCB00 and Vivinex† iSert† XY1 IOLs; n=10 per IOL; p<.005

    **Based on in vitro examinations of glistenings, surface haze and SSNGs; as compared to Claeron CNA0T0, TECNIS ZCB00, TECNIS OptiBlue, Eternity W-60 and enVista MX60; n=30 per group; p<.001

    †Trademarks are the property of their respective owners.

    What is Clareon® Vivity®?

     

    Clareon® Vivity® wavefront-shaping technology explained.

    ­
      Wavefront-Shaping Technology
      The Clareon® Vivity® IOL is a presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-2

       

      ✓ The Clareon® Vivity® IOL uses wavefront-shaping technology1,2

       

      ✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2

       

      ✓ Surface Transition #2: A small curvature change (across the ~2.2 mm region) that shifts the wavefront to utilise all available light energy2

      Golden 3-dimensional image of the Clareon Vivity IOL.
      Surface Transition #1
      The Clareon® Vivity® IOL is a presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-2

       

      ✓ The Clareon® Vivity® IOL uses wavefront-shaping technology1,2

       

      ✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2

       

      ✓ Surface Transition #2: A small curvature change (across the ~2.2 mm region) that shifts the wavefront to utilise all available light energy2

      Golden 3-dimensional image of the Clareon Vivity IOL with white graphic lines that draw focus to the middle of the lens, highlighting the slightly elevated smooth plateau that contributes to the lens’s wavefront-shaping technology.
      Surface Transition #2
      The Clareon® Vivity® IOL is a presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-2

       

      ✓ The Clareon® Vivity® IOL uses wavefront-shaping technology1,2

       

      ✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2

       

      ✓ Surface Transition #2: A small curvature change (across the ~2.2 mm region) that shifts the wavefront to utilise all available light energy2

      Golden 3-dimensional image of the Clareon Vivity IOL with white graphic lines that draw focus to the middle of the lens highlighting the small curvature change that contributes to the lens’s wavefront-shaping technology.

      Surface Transition Elements Affect Light Energy Distribution*

       

      The proprietary, wavefront-shaping design creates a monofocal visual disturbance profile and a continuous range of vision for patients.1-4

      With the Clareon® Vivity® IOL, light spans a continuous focal range, instead of being split amongst multiple focal points.20

       

      Wavefront-Shaping Technology (X-WAVE™):

      Creates a Continuous Extended Focal Range Instead of Multiple Fotal Points17*

      A graphic illustrating the simulated range of vision based on light intensity distribution with four different IOLs. The Clareon monofocal IOL provides distance vision. The TECNIS Symfony IOL provides distance, intermediate and near vision. The Zeiss AT LARA IOL provides vision at distance and two intermediate focal points. The Clareon Vivity IOL provides a continuous range of vision from distance to functional near.

      *Simulated photopic through-focus point spread function (light intensity [energy]) – polychromatic.

      †Trademarks are the property of their respective owners.

      ­

      Hear What Surgeons Are Saying About The Vivity® IOL

       

      “This is a really exciting lens… We have been looking for it for a while.” 

      - Dr. Michael Lawless, MBBS, FRANZCO, FRACS

      ­

      See Why Patients Say The Vivity® IOL Was The Right Choice For Them

       

      “In my case, [Vivity®] was the perfect choice… I’m extremely happy and extremely satisfied.”

      - Roger, Spain

      Roger, Spain

       

      Roger is representative of patients whose active lifestyle makes them best suited for a lens that can offer them a continuous range of vision.

      Dr. Angela Jennings, Australia

       

      Dr. Angela Jennings is an ophthalmologist and an AcrySof IQ Vivity® IOL patient who represents many patients who are considered unsuitable for PCIOLs; these include people with Type A personalities, people who drive at night, and who have mild glaucoma.

      The patients that appear in these videos express opinions that are their own, based on their own experiences. These videos are not a substitute for medical advice or information. The patients received a modest compensation for their participation in these videos.

      Technical Specifications

      Table of specifications for Clareon Vivity

      *Clinically validated. †Theoretical.

      Instructions for Use (IFU)

       

      For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.

      Visit IFU Database
      ­

      Alcon Experience Academy

       

      For relevant training content from industry thought leaders

      Visit AEA Portal

      References:

      1. Clareon® Vivity® Extended Vision IOL Directions for Use.

      2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.

      3. Bala C, et al. Multi-country clinical outcomes of a new nondiffractive presbyopia-correcting intraocular lens. J Cataract Refract Surg. 2021: Ahead of print. doi:10.1097/j.jcrs.0000000000000712.

      4. McCabe C, Berdahl J, Reiser H, et al. Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a non-diffractive design. J Cataract Refract Surg. 2022;48(11):1297-1304.

      5. Baur I, et al. Visualization of ray propagation through extended depth-of-focus intraocular lenses. Diagnostics 2022, 12, 2667.

      6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020. 

      7. Lawless M. Insight news. “An IOL to change the cataract surgery paradigm?” available at “https://insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/”. Accessed 17 Jul 2020.

      8. Ahmed I, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021.

      9. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.

      10. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.

      11. Alcon Data on File. TDOC-0057291. 10 Mar 2020.

      12. Stanojcic N, O’Brart D, Hull C, et al. Visual and refractive outcomes and glistenings occurrence after implantation of 2 hydrophobic acrylic aspheric monofocal IOLs. J Cataract Refract Surg. 2020;46(7):986-994.

      13. Lane S, et al. Evaluation of intraocular lens mechanical stability. J Cataract Refract Surg. 2019;45:501-506.

      14. Walters T, et al. Rotational Stability of the Clareon Monofocal Aspheric Hydrophobic Acrylic Intraocular Lens 6 Months After Implantation. Clin Ophthalmol 2022;16:401.

      15. Von Tress M et al. A meta-analysis of Nd:YAG capsulotomy rates for two hydrophobic intraocular lens materials. Clin Ophthalmol 2018;12:1125.

      16. AcrySof® IQ Aspheric IOL Product Information.

      17. Clareon® Monofocal IOL Directions for Use.

      18. Alcon Data on File, REP-206331. 2021.

      19. Alcon Data on File, ILI875-P001. 2021.

      20. Kohnen T, et al. The Novel Optical Design and Clinical Classification of a Wavefront-Shaping Presbyopia-Correcting Intraocular Lens. Clin Ophthalmol. 2023:17 2449–2457.

       

      Please refer to product direction for use for complete list of indications, contraindications and warnings.

      ©2025 Alcon Laboratories Pty Ltd. AUS: 1800 224 153; Auckland NZ: 0800 101 106. ANZ-CLV-2400029
      Australia
      Alcon See Briliantly